Cargando…
Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy
Dysregulation of Wnt/β-catenin signaling contributes to the development of diabetic retinopathy by inducing retinal inflammation, vascular leakage, and neovascularization. Here, we evaluated the inhibitory effect of a monoclonal antibody (Mab) specific for the E1E2 domain of Wnt coreceptor low-densi...
Autores principales: | Lee, Kyungwon, Hu, Yang, Ding, Lexi, Chen, Ying, Takahashi, Yusuke, Mott, Robert, Ma, Jian-xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478529/ https://www.ncbi.nlm.nih.gov/pubmed/22891217 http://dx.doi.org/10.2337/db11-0300 |
Ejemplares similares
-
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis
por: Cheng, Rui, et al.
Publicado: (2016) -
Inhibition of Connective Tissue Growth Factor Overexpression in Diabetic Retinopathy by SERPINA3K via Blocking the WNT/β-Catenin Pathway
por: Zhang, Bin, et al.
Publicado: (2010) -
Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013) -
Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα
por: Chen, Qian, et al.
Publicado: (2017) -
New Diabetes Diagnostic Threshold of Hemoglobin A(1c) and the 3-Year Incidence of Retinopathy
por: Tsugawa, Yusuke, et al.
Publicado: (2012)